{"status": "Ok", "redirect_url": "https://www.globenewswire.com/news-release/2026/05/01/3286249/0/en/Celcuity-s-Phase-3-VIKTORIA-1-Trial-Achieves-Primary-Endpoint-With-Clinically-Meaningful-Improvement-in-Progression-Free-Survival-in-PIK3CA-Mutant-Cohort.html", "message": "News view counter 698677 successfully enlarged"}